PLN/HUF Spot/
2024-07-03 7:31:37 AM | Chg. -0.01282 | Volume | Bid7:31:37 AM | Ask7:31:37 AM | High | Low |
---|---|---|---|---|---|---|
91.62731HUF | -0.01% | 18,580 Turnover: 1.7 mill. |
91.62761Bid Size: 1 | 91.62702Ask Size: 1 | 91.74116 | 91.53248 |
GlobeNewswire
06-13
Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
GlobeNewswire
06-12
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
06-06
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the S...
GlobeNewswire
05-22
Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society Inte...
GlobeNewswire
05-14
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...
GlobeNewswire
05-07
Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of th...
GlobeNewswire
05-06
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
05-02
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufa...
GlobeNewswire
04-24
F3 Uranium to Present at the OTC Metals & Mining Virtual Investor Conference on April 30th
GlobeNewswire
03-27
Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society Internati...
GlobeNewswire
03-12
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopath...
GlobeNewswire
02-27
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results